4/29/2023 0 Comments Novamind cse![]() ![]() Terran Biosciences Acquires Blumentech S.L. “By partnering with SRx Health Solutions and BioScript, we can leverage their established clinic network and operational excellence in specialty medical treatments to introduce our mental health treatments in an expedient and capital efficient manner and importantly, working with an infrastructure that enables scaling” said Rob Tessarolo, President and CEO of NeonMind Biosciences. Initially these clinics will offer IV-Ket, and is set to open the first location this summer in Mississauga, Ontario. NeonMind Biosciences (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) announced plans this week to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript Solutions, leading Canadian specialty healthcare services and medical treatment providers. NeonMind to Launch 10 Clinics for Innovative Treatments When the transaction is finalized, each Novamind share you own will automatically be transformed into 0.84 of a Numinus share. ![]() ![]() If you currently hold Novamind stock, you do not need to do anything. Following the transaction, expected to be completed in June, the combined company will have 13 wellness clinics and be positioned as a leading psychedelic-assisted therapy provider in North America, leading its peer group in revenue with $9.9 million in annual revenue. This week in psychedelic business news, we are witnessing the first major psychedelics merger with Numinus Wellness (TSX: NUMI) (OTCQX: NUMIF) announcing plans to acquire Novamind (CSE: NM) (OTCQB: NVMDF) in an all-share transaction, by way of a court-approved plan of arrangement, for total consideration of approximately $26.2 million (CAD) on a fully diluted in-the-money basis. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |